Hem › Lupus › Georgia › Atlanta
Kliniska studier för Lupus i Atlanta, GA
6 studier för Lupus söker deltagare vid platser i och runt Atlanta (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
RekryterarFas 3
- Emory University School of Medicine, Atlanta
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RekryterarFas 1/2
- Research Site, Atlanta
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
RekryterarObservationsstudie
- Local Institution - 0069, Atlanta
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RekryterarFas 1/2
- Emory University, Atlanta
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
RekryterarFas 3
- Emory University School of Medicine, Atlanta
Lupus Landmark Study: A Prospective Registry and Biorepository
RekryterarObservationsstudie
- Emory University, Atlanta
Lupus-studier i andra städer
- New York City, NY18 studier
- Houston, TX13 studier
- Durham, NC12 studier
- Washington, DC10 studier
- Miami, FL10 studier
- Tampa, FL9 studier
- Philadelphia, PA9 studier
- Clearwater, FL8 studier
- Santa Monica, CA8 studier
- Oklahoma City, OK8 studier
- Boston, MA8 studier
- Los Angeles, CA8 studier
Andra studier i Atlanta
- Cancer (alla typer)49 studier
- Icke-småcellig lungcancer47 studier
- Bröstcancer41 studier
- Multipelt myelom41 studier
- Prostatacancer33 studier
- Akut myeloid leukemi30 studier
- Äggstockscancer29 studier
- Lungcancer29 studier
- Kolorektal cancer29 studier
- Metastaserande cancer28 studier
- Hjärtsvikt25 studier
- Major depression25 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.